# Grant Opportunities Report: Non-Dilutive Funding for HelioFlux
**Generated:** February 11, 2026

---

## ⚠️ CRITICAL UPDATE: SBIR/STTR EXPIRED

**The SBIR/STTR programs EXPIRED on October 1, 2025.**

Congress has NOT reauthorized the programs. Current status:
- No new applications being accepted
- Existing awardees continue receiving funding (until Jan 30, 2026)
- Reauthorization pending but uncertain

**Implication:** Cannot rely on SBIR/STTR as a funding source right now.

---

## ACTIVE GRANT OPPORTUNITIES

### 1. Prevent Cancer Foundation
**Website:** preventcancer.org/research/
**Focus:** Cancer prevention and early detection
**Status:** ACTIVE - accepting applications

**Why relevant:** 
- Explicitly funds early detection innovations
- Smaller grants but aligned mission
- Good for pilot data

---

### 2. The Mark Foundation for Cancer Research
**Program:** Early Detection Award
**Website:** themarkfoundation.org/early-detection-award/
**LOI Deadline:** March 10, 2025 (check for 2026 cycle)
**Focus:** Technologies for earlier cancer detection

**Why relevant:**
- Specifically targets early detection tech
- Well-funded foundation
- Strong network for follow-on

---

### 3. American Cancer Society (ACS)
**Website:** cancer.org/research/we-fund-cancer-research/apply-research-grant.html
**Deadline:** June 1 annually
**Status:** ACTIVE

**Types of grants:**
- Research grants
- IRG (Institutional Research Grants)
- Various fellowship programs

---

### 4. AACR (American Association for Cancer Research)
**Website:** aacr.org/professionals/research-funding/
**Focus:** All stages of cancer research
**Note:** Multiple grant programs throughout year

---

### 5. V Foundation for Cancer Research
**Website:** v.org/research-overview/our-research-grants/
**Programs:**
- V Scholar (early career)
- Translational grants
- Game-Changer grants

**Note:** Founded by Jim Valvano, strong brand recognition

---

### 6. NCI Division of Cancer Prevention
**Website:** prevention.cancer.gov/funding-and-grants/funding-opportunities
**Status:** Check for non-SBIR mechanisms
**Note:** NIH moving all NOFOs to Grants.gov starting FY26

---

## ALTERNATIVE FUNDING PATHS

### 1. State-Level Grants
- **CPRIT (Texas)** - Cancer Prevention Research Institute of Texas
- **California Initiative to Advance Precision Medicine**
- Check university partnerships in states with cancer funding

### 2. Accelerators with Funding
- **IndieBio** - SOSV accelerator, $500K seed + lab space
- **Y Combinator** - Has funded diagnostics startups
- **StartX (Stanford)** - Healthcare focus

### 3. Corporate Grants
- **Johnson & Johnson Innovation**
- **Pfizer Global Medical Grants**
- **Hamamatsu** (existing relationship)

### 4. University/Research Partnerships
- Leverage Nirosha's lab funding indirectly
- Collaborative grants with academic institutions

---

## TIMELINE CONSIDERATIONS

| Grant | Typical Cycle | Award Size |
|-------|---------------|------------|
| Prevent Cancer | Rolling | $50K-150K |
| Mark Foundation | Annual (March LOI) | Up to $1M |
| ACS | June deadline | $150K-600K |
| AACR | Various | $50K-450K |
| V Foundation | Various | $100K-600K |

---

## RECOMMENDATIONS

1. **Don't count on SBIR/STTR** — program is in limbo
2. **Apply to Mark Foundation** ASAP when 2026 cycle opens
3. **Prevent Cancer Foundation** — quick turnaround, aligned mission
4. **Consider IndieBio** — accelerator + funding + lab space
5. **Stack applications** — apply to multiple simultaneously

---

## ACTION ITEMS

- [ ] Check Mark Foundation for 2026 LOI dates
- [ ] Prepare Prevent Cancer Foundation application
- [ ] Research state-level grants (Texas CPRIT?)
- [ ] Explore IndieBio application timeline
- [ ] Follow up with Hamamatsu on partnership funding

---

*Sources: NIH Guide, Foundation websites, E.B. Howard Consulting analysis*
